Nodular Sclerosis Hodgkin Lymphoma, Lymph Nodes of Axilla and Upper Limb (C81.14)

Name of the Condition

• Common Name: Nodular Sclerosis Hodgkin Lymphoma
• Medical Terms: Nodular Sclerosis Hodgkin's Disease, NSHL

Summary

Nodular sclerosis Hodgkin lymphoma (NSHL) is a subtype of Hodgkin lymphoma defined by Reed-Sternberg cells and a fibrous nodular pattern in affected lymph nodes. This specific code (C81.14) indicates involvement of lymph nodes in the axilla and upper limb regions. NSHL is the most common subtype of Hodgkin lymphoma and typically presents with painless lymph node enlargement. It tends to affect young adults and has a favorable prognosis with standard treatment.

Causes

The exact cause of NSHL is not fully understood, but it is believed to result from a combination of genetic and environmental factors. Viral infections, such as Epstein-Barr virus (EBV), may contribute to its development, though not all cases are associated with EBV. Genetic predisposition and immune system interactions are also thought to play a role.

Risk Factors

• Age: Most commonly diagnosed in young adults (15-35 years) and adolescents.
• Gender: Slightly more prevalent in females.
• Family History: Having a first-degree relative with lymphoma may increase risk.
• Epstein-Barr Virus: Prior infection may elevate susceptibility.

Symptoms

• Painless swelling of lymph nodes, often in the axilla or upper limb.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintentional weight loss.
• Itching (pruritus).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or PET scans), and biopsy of the affected lymph node. Histopathological examination confirms the presence of Reed-Sternberg cells and the characteristic fibrous nodular pattern. Staging is performed to determine the extent of disease and guide treatment.

Treatment Options

Treatment typically includes chemotherapy, often combined with radiation therapy for localized disease. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone). Stem cell transplantation may be considered for relapsed or refractory cases.

Prognosis and Follow-Up

NSHL has a favorable prognosis, with high cure rates, especially in early-stage disease. Long-term follow-up is recommended to monitor for recurrence or late effects of treatment, such as secondary malignancies or cardiovascular issues.

Complications

• Recurrence of lymphoma.
• Treatment-related side effects (e.g., infertility, secondary cancers).
• Infection risk due to immunosuppression.
• Lymphedema in the affected limb.

Lifestyle & Prevention

• Maintain a healthy lifestyle to support immune function.
• Avoid known carcinogens (e.g., tobacco).
• Stay up-to-date with vaccinations to reduce infection risk.
• Follow recommended screening for late effects of treatment.

When to Seek Professional Help

Seek medical attention for persistent, painless lymph node swelling, unexplained weight loss, fever, or night sweats. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

Use C81.14 for nodular sclerosis Hodgkin lymphoma involving lymph nodes of the axilla and upper limb. Ensure documentation specifies the anatomical site to support code assignment. Verify that the diagnosis aligns with histopathological confirmation of NSHL and exclude other lymphoma subtypes.